The Difference in the Effectiveness of Anti-IL-5 Antibodies and Anti-IL-5rα Antibodies in Severe Bronchial Asthma

被引：0
|
作者：
Nishimura, N. [1 ]
Imai, R. [1 ]
Nakamura, T. [1 ]
So, C. [1 ]
Okafuji, K. [1 ]
Kitamura, A. [1 ]
Tomishima, Y. [1 ]
Jinta, T. [1 ]
机构：
[1] St Lukes Int Hosp, Thorac Ctr, Dept Pulm Med, Chuo City, Tokyo, Japan
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2024年 / 209卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A5390
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Changes in Serum MicroRNAs after Anti-IL-5 Biological Treatment of Severe Asthma
    Rial, Manuel J.
    Canas, Jose A.
    Rodrigo-Munoz, Jose M.
    Valverde-Monge, Marcela
    Sastre, Beatriz
    Sastre, Joaquin
    del Pozo, Victoria
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (07)
  • [42] Heterogeneous Response of Airway Eosinophilia to Anti-IL-5 Biologics in Severe Asthma Patients
    Sokic, Marusa Kopac
    Rijavec, Matija
    Korosec, Peter
    Bidovec-Stojkovic, Urska
    Kern, Izidor
    Vantur, Romana
    Skrgat, Sabina
    JOURNAL OF PERSONALIZED MEDICINE, 2022, 12 (01):
  • [43] Efficacy of dupilumab in patients with aspirin-exacerbated respiratory disease and previous inadequate response to anti-IL-5 or anti-IL-5Rα in a real-world setting
    Bavaro, Nicole
    Gakpo, Deborah
    Mittal, Anisha
    Bensko, Jillian C.
    Laidlaw, Tanya M.
    Buchheit, Kathleen M.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2021, 9 (07): : 2910 - +
  • [44] Anti-IL-5 therapy and DRESS
    Khan, Sujoy
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2010, 182 (09) : 941 - 941
  • [45] Benralizumab attenuates blood and airway eosinophilia in severe asthmatics with inadequate response to anti-IL-5 neutralizing antibodies
    Mukherjee, M.
    Bhalla, A.
    Venegas-Garrido, C.
    Huang, C.
    Radford, K.
    Kjarsgaard, M.
    Lauks, S.
    Son, K.
    Lavigne, N.
    Sehmi, R.
    O'Byrne, P.
    Nair, P.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [46] Serum Amphiregulin expression in severe asthma patients treated with anti-IL-5 therapy
    Bagnasco, Diego
    Riccio, Anna Maria
    De Ferrari, Laura
    Massolo, Alessandro
    Caminati, Marco
    Manfredi, Andrea
    Senna, Gianenrico
    Passalacqua, Giovanni
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [47] Suboptimal treatment response to anti-IL-5 monoclonal antibodies in severe eosinophilic asthmatics with airway autoimmune phenomena
    Mukherjee, Manali
    Forero, David Felipe
    Tran, Stephanie
    Boulay, Marie-Eve
    Bertrand, Mylene
    Bhalla, Anurag
    Cherukat, Jayant
    Al-Hayyan, Hajar
    Ayoub, Anmar
    Revill, Spencer D.
    Javkar, Tanvi
    Radford, Katherine
    Kjarsgaard, Melanie
    Huang, Chynna
    Dvorkin-Gheva, Anna
    Ask, Kjetil
    Olivenstein, Ronald
    Dendukuri, Nandini
    Lemiere, Catherine
    Boulet, Louis-Philippe
    Martin, James G.
    Nair, Parameswaran
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56 (04)
  • [48] Real-life effectiveness of anti-IL-5(-receptor) antibody treatment in patients with severe eosinophilic asthma
    Korn, Stephanie
    Ehrhard, Lucas
    Voigt, Stefanie
    Buhl, Roland
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [49] Successful treatment of eosinophilic otitis media associated with severe bronchial asthma with an anti-IL-5 monoclonal antibody, mepolizumab
    Suzaki, Isao
    Kimura, Yurika
    Tanaka, Akihiko
    Hirano, Kojiro
    Ishibashi, Atsushi
    Mizuyoshi, Tomomi
    Ando, Izumi
    Kitajima, Tatsuya
    Watanabe, So
    Hinohira, Yasuyuki
    Kobayashi, Hitome
    AURIS NASUS LARYNX, 2019, 46 (01) : 141 - 146
  • [50] Anti-IL-5 and hypereosinophilic syndromes
    Sutton, SA
    Assa'ad, AH
    Rothenberg, ME
    CLINICAL IMMUNOLOGY, 2005, 115 (01) : 51 - 60
12345